

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * intestinal absorption (GO:0050892) | 9.75506513 |
| 2 | angiotensin maturation (GO:0002003) | 9.71501678 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.90255582 |
| 4 | vitamin A metabolic process (GO:0006776) | 6.92561352 |
| 5 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.51368303 |
| 6 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.39629733 |
| 7 | regulation of guanylate cyclase activity (GO:0031282) | 6.25264791 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.85564520 |
| 9 | drug metabolic process (GO:0017144) | 5.66251980 |
| 10 | positive regulation of triglyceride lipase activity (GO:0061365) | 5.63794875 |
| 11 | positive regulation of lipoprotein lipase activity (GO:0051006) | 5.63794875 |
| 12 | phospholipid efflux (GO:0033700) | 5.42234854 |
| 13 | fructose metabolic process (GO:0006000) | 5.33422721 |
| 14 | plasma lipoprotein particle assembly (GO:0034377) | 5.31568486 |
| 15 | exogenous drug catabolic process (GO:0042738) | 5.28080607 |
| 16 | urea metabolic process (GO:0019627) | 5.28053559 |
| 17 | virion attachment to host cell (GO:0019062) | 5.27675776 |
| 18 | adhesion of symbiont to host cell (GO:0044650) | 5.27675776 |
| 19 | actin filament depolymerization (GO:0030042) | 5.25094231 |
| 20 | regulation of triglyceride catabolic process (GO:0010896) | 5.23538693 |
| 21 | cellular glucuronidation (GO:0052695) | 5.19692845 |
| 22 | regulation of cholesterol esterification (GO:0010872) | 5.18426621 |
| 23 | urea cycle (GO:0000050) | 5.15719592 |
| 24 | glucuronate metabolic process (GO:0019585) | 5.07035919 |
| 25 | uronic acid metabolic process (GO:0006063) | 5.07035919 |
| 26 | protein-lipid complex assembly (GO:0065005) | 4.99371851 |
| 27 | modified amino acid transport (GO:0072337) | 4.96984544 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.84338107 |
| 29 | bile acid and bile salt transport (GO:0015721) | 4.78701771 |
| 30 | lipoprotein metabolic process (GO:0042157) | 4.76924885 |
| 31 | ethanol oxidation (GO:0006069) | 4.73052519 |
| 32 | drug catabolic process (GO:0042737) | 4.66553822 |
| 33 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.63058052 |
| 34 | peptide catabolic process (GO:0043171) | 4.59860633 |
| 35 | purine nucleotide salvage (GO:0032261) | 4.55339865 |
| 36 | adhesion of symbiont to host (GO:0044406) | 4.53342642 |
| 37 | flavonoid metabolic process (GO:0009812) | 4.50043277 |
| 38 | glucose 6-phosphate metabolic process (GO:0051156) | 4.37003330 |
| 39 | renal system process involved in regulation of blood volume (GO:0001977) | 4.34392172 |
| 40 | regulation of systemic arterial blood pressure (GO:0003073) | 4.33537290 |
| 41 | omega-hydroxylase P450 pathway (GO:0097267) | 4.32937847 |
| 42 | cholesterol efflux (GO:0033344) | 4.30599184 |
| 43 | regulation of cellular extravasation (GO:0002691) | 4.11276996 |
| 44 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.09244556 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.05964105 |
| 46 | alkaloid metabolic process (GO:0009820) | 4.05036862 |
| 47 | bile acid metabolic process (GO:0008206) | 4.04617154 |
| 48 | purine nucleobase biosynthetic process (GO:0009113) | 4.03861577 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.91441524 |
| 50 | hormone catabolic process (GO:0042447) | 3.89354058 |
| 51 | arginine metabolic process (GO:0006525) | 3.83052990 |
| 52 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.82885670 |
| 53 | regulation of cGMP biosynthetic process (GO:0030826) | 3.79769979 |
| 54 | cholesterol homeostasis (GO:0042632) | 3.78058222 |
| 55 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.73963702 |
| 56 | ethanol metabolic process (GO:0006067) | 3.73880471 |
| 57 | sterol homeostasis (GO:0055092) | 3.73841182 |
| 58 | * digestive system process (GO:0022600) | 3.73813781 |
| 59 | response to hepatocyte growth factor (GO:0035728) | 3.72845755 |
| 60 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.72845755 |
| 61 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.67937811 |
| 62 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.66274968 |
| 63 | hydrogen peroxide catabolic process (GO:0042744) | 3.64211762 |
| 64 | nucleobase biosynthetic process (GO:0046112) | 3.63125913 |
| 65 | negative regulation of cholesterol transport (GO:0032375) | 3.62284326 |
| 66 | negative regulation of sterol transport (GO:0032372) | 3.62284326 |
| 67 | lipoprotein transport (GO:0042953) | 3.60674936 |
| 68 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.55815706 |
| 69 | high-density lipoprotein particle remodeling (GO:0034375) | 3.53556140 |
| 70 | vitamin transmembrane transport (GO:0035461) | 3.53251231 |
| 71 | defense response to fungus (GO:0050832) | 3.53138546 |
| 72 | sterol transport (GO:0015918) | 3.50239969 |
| 73 | cholesterol transport (GO:0030301) | 3.50239969 |
| 74 | glycosphingolipid catabolic process (GO:0046479) | 3.49749735 |
| 75 | complement activation, classical pathway (GO:0006958) | 3.48690398 |
| 76 | glycolipid catabolic process (GO:0019377) | 3.48103265 |
| 77 | regulation of lipoprotein metabolic process (GO:0050746) | 3.47287294 |
| 78 | regulation of cholesterol homeostasis (GO:2000188) | 3.45585688 |
| 79 | innate immune response in mucosa (GO:0002227) | 3.45569472 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 3.43176087 |
| 81 | protein-lipid complex remodeling (GO:0034368) | 3.43176087 |
| 82 | macromolecular complex remodeling (GO:0034367) | 3.43176087 |
| 83 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.40708059 |
| 84 | vitamin transport (GO:0051180) | 3.39337796 |
| 85 | homocysteine metabolic process (GO:0050667) | 3.39187131 |
| 86 | regulation of vitamin metabolic process (GO:0030656) | 3.38768270 |
| 87 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.37875385 |
| 88 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.37875385 |
| 89 | plasma lipoprotein particle organization (GO:0071827) | 3.36793735 |
| 90 | vitamin biosynthetic process (GO:0009110) | 3.36187635 |
| 91 | NADH metabolic process (GO:0006734) | 3.32272440 |
| 92 | protein-lipid complex subunit organization (GO:0071825) | 3.30665028 |
| 93 | digestion (GO:0007586) | 3.29373139 |
| 94 | drug transmembrane transport (GO:0006855) | 3.28166718 |
| 95 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.27576002 |
| 96 | trophectodermal cell differentiation (GO:0001829) | 3.25207594 |
| 97 | sulfur compound transport (GO:0072348) | 3.24068242 |
| 98 | positive regulation of pseudopodium assembly (GO:0031274) | 3.22159063 |
| 99 | drinking behavior (GO:0042756) | 3.20533428 |
| 100 | peptide hormone processing (GO:0016486) | 3.19536933 |
| 101 | low-density lipoprotein particle remodeling (GO:0034374) | 3.17466387 |
| 102 | proline metabolic process (GO:0006560) | 3.16312295 |
| 103 | response to hydroperoxide (GO:0033194) | 3.16250570 |
| 104 | nucleotide salvage (GO:0043173) | 3.15649574 |
| 105 | disruption of cells of other organism (GO:0044364) | 3.15146866 |
| 106 | killing of cells of other organism (GO:0031640) | 3.15146866 |
| 107 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.15118596 |
| 108 | phenylpropanoid metabolic process (GO:0009698) | 3.11645694 |
| 109 | regulation of cGMP metabolic process (GO:0030823) | 3.10690082 |
| 110 | negative regulation of B cell apoptotic process (GO:0002903) | 3.10574461 |
| 111 | oxaloacetate metabolic process (GO:0006107) | 3.09916834 |
| 112 | midgut development (GO:0007494) | 3.08451840 |
| 113 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.07373304 |
| 114 | complement activation, alternative pathway (GO:0006957) | 3.06557766 |
| 115 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.06467024 |
| 116 | complement activation (GO:0006956) | 3.04982416 |
| 117 | transcytosis (GO:0045056) | 3.04901888 |
| 118 | DNA unwinding involved in DNA replication (GO:0006268) | 3.02495725 |
| 119 | oligosaccharide catabolic process (GO:0009313) | 3.00997979 |
| 120 | renal absorption (GO:0070293) | 2.99799588 |
| 121 | regulation of protein activation cascade (GO:2000257) | 2.99458515 |
| 122 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.95880181 |
| 123 | very long-chain fatty acid metabolic process (GO:0000038) | 2.95271270 |
| 124 | regulation of cholesterol metabolic process (GO:0090181) | 2.94717357 |
| 125 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.94108634 |
| 126 | urate metabolic process (GO:0046415) | 2.93513561 |
| 127 | regulation of complement activation (GO:0030449) | 2.93239566 |
| 128 | regulation of bile acid biosynthetic process (GO:0070857) | 2.90383808 |
| 129 | pentose-phosphate shunt (GO:0006098) | 2.89482802 |
| 130 | drug transport (GO:0015893) | 2.88705275 |
| 131 | heterochromatin organization (GO:0070828) | 2.86846130 |
| 132 | NADPH regeneration (GO:0006740) | 2.86219915 |
| 133 | positive regulation of lipid catabolic process (GO:0050996) | 2.82891304 |
| 134 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.81463579 |
| 135 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.81463579 |
| 136 | endocrine process (GO:0050886) | 2.81463579 |
| 137 | mucosal immune response (GO:0002385) | 2.81062780 |
| 138 | hydrogen peroxide metabolic process (GO:0042743) | 2.78583162 |
| 139 | antibacterial humoral response (GO:0019731) | 2.76413471 |
| 140 | glycolytic process (GO:0006096) | 2.75589985 |
| 141 | sulfate transmembrane transport (GO:1902358) | 2.74325518 |
| 142 | removal of superoxide radicals (GO:0019430) | 2.72072099 |
| 143 | cellular response to superoxide (GO:0071451) | 2.72072099 |
| 144 | cellular response to oxygen radical (GO:0071450) | 2.72072099 |
| 145 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.71136175 |
| 146 | regulation of digestive system process (GO:0044058) | 2.70403396 |
| 147 | antimicrobial humoral response (GO:0019730) | 2.68148797 |
| 148 | regulation of sterol transport (GO:0032371) | 2.66085151 |
| 149 | regulation of cholesterol transport (GO:0032374) | 2.66085151 |
| 150 | fat-soluble vitamin metabolic process (GO:0006775) | 2.65813937 |
| 151 | organ or tissue specific immune response (GO:0002251) | 2.61350957 |
| 152 | thyroid hormone metabolic process (GO:0042403) | 2.57599503 |
| 153 | sulfate transport (GO:0008272) | 2.55753221 |
| 154 | intestinal cholesterol absorption (GO:0030299) | 10.0402018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.19501188 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.12231264 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.48805917 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.38488863 |
| 5 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.06387730 |
| 6 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.03897703 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.97105495 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.92659951 |
| 9 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.88479119 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.69236714 |
| 11 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.61236520 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.61026097 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.48842619 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.43055127 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.28420020 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.26184889 |
| 17 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.11462363 |
| 18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.09387831 |
| 19 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.05881924 |
| 20 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.01239612 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.99531484 |
| 22 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.98116902 |
| 23 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.98038104 |
| 24 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.97395343 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.89217657 |
| 26 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.89034723 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.88945022 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88907509 |
| 29 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.87840191 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86254139 |
| 31 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.85960840 |
| 32 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.84722618 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81263952 |
| 34 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.80404398 |
| 35 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.79306490 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.78664568 |
| 37 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.78132832 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.77147608 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.74105353 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.71014912 |
| 41 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.67775669 |
| 42 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.65982167 |
| 43 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.65199405 |
| 44 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.60256644 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.60070552 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57251641 |
| 47 | ATF3_27146783_Chip-Seq_COLON_Human | 1.55326844 |
| 48 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.54746227 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54389220 |
| 50 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.51503558 |
| 51 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50382260 |
| 52 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.46925135 |
| 53 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.44566360 |
| 54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43356137 |
| 55 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.42786233 |
| 56 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41493733 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38203682 |
| 58 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.37442928 |
| 59 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.34425284 |
| 60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34294467 |
| 61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32610424 |
| 62 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.32533801 |
| 63 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.31961444 |
| 64 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.30973841 |
| 65 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29662197 |
| 66 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.27902902 |
| 67 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.23540928 |
| 68 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.21575449 |
| 69 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20900060 |
| 70 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19859522 |
| 71 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18137940 |
| 72 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.17203319 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16624494 |
| 74 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.13465889 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12932787 |
| 76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11695642 |
| 77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11608926 |
| 78 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10972950 |
| 79 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10470940 |
| 80 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.10312506 |
| 81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10105158 |
| 82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.10033901 |
| 83 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09468741 |
| 84 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09214425 |
| 85 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08023846 |
| 86 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.07843119 |
| 87 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.07709488 |
| 88 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07220507 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06291377 |
| 90 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05843422 |
| 91 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.05649846 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.05406565 |
| 93 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04753545 |
| 94 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.04658640 |
| 95 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04220312 |
| 96 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04140321 |
| 97 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03939644 |
| 98 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02339012 |
| 99 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.01998934 |
| 100 | MYC_22102868_ChIP-Seq_BL_Human | 1.01143143 |
| 101 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99949679 |
| 102 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.99079985 |
| 103 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98995847 |
| 104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98934095 |
| 105 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.98887500 |
| 106 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98030674 |
| 107 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.97721992 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97548153 |
| 109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97532167 |
| 110 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97514708 |
| 111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97343542 |
| 112 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.96672372 |
| 113 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.96432749 |
| 114 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96337332 |
| 115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95321637 |
| 116 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.94891110 |
| 117 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94854383 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94452305 |
| 119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93686733 |
| 120 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.93590095 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92697214 |
| 122 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.92335477 |
| 123 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92046767 |
| 124 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91362293 |
| 125 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.91300149 |
| 126 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.91153891 |
| 127 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.90501712 |
| 128 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.90165388 |
| 129 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.89726691 |
| 130 | P68_20966046_ChIP-Seq_HELA_Human | 0.89102350 |
| 131 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88464713 |
| 132 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.88286313 |
| 133 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.88221777 |
| 134 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87218366 |
| 135 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86992722 |
| 136 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.86830743 |
| 137 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86360458 |
| 138 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.85089476 |
| 139 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.85016773 |
| 140 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.84366221 |
| 141 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.84016310 |
| 142 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83820283 |
| 143 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83820209 |
| 144 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83264435 |
| 145 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.83195031 |
| 146 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83170787 |
| 147 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83128863 |
| 148 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82929012 |
| 149 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.82823751 |
| 150 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81360858 |
| 151 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.81283726 |
| 152 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81230534 |
| 153 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80433727 |
| 154 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78157963 |
| 155 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77941629 |
| 156 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.77920789 |
| 157 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77858181 |
| 158 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.77403206 |
| 159 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76818361 |
| 160 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76597213 |
| 161 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.75102312 |
| 162 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.74595569 |
| 163 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.73833791 |
| 164 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73466234 |
| 165 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.73310417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.14147244 |
| 2 | * MP0001666_abnormal_nutrient_absorption | 4.34260769 |
| 3 | MP0009840_abnormal_foam_cell | 4.21164009 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 3.70499371 |
| 5 | MP0003183_abnormal_peptide_metabolism | 3.63271238 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.88432119 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.86754631 |
| 8 | MP0005084_abnormal_gallbladder_morpholo | 2.48160986 |
| 9 | MP0000537_abnormal_urethra_morphology | 2.46238714 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.42654328 |
| 11 | MP0000462_abnormal_digestive_system | 2.42518533 |
| 12 | MP0003868_abnormal_feces_composition | 2.34643673 |
| 13 | MP0003693_abnormal_embryo_hatching | 2.34068118 |
| 14 | MP0003252_abnormal_bile_duct | 2.32760826 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.20192989 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.15035337 |
| 17 | * MP0010329_abnormal_lipoprotein_level | 2.08369068 |
| 18 | MP0005409_darkened_coat_color | 2.04788759 |
| 19 | MP0004147_increased_porphyrin_level | 2.01958758 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 1.98032279 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.95436893 |
| 22 | MP0005377_hearing/vestibular/ear_phenot | 1.83016424 |
| 23 | MP0003878_abnormal_ear_physiology | 1.83016424 |
| 24 | MP0003123_paternal_imprinting | 1.82872838 |
| 25 | MP0006054_spinal_hemorrhage | 1.81664707 |
| 26 | MP0004957_abnormal_blastocyst_morpholog | 1.79760508 |
| 27 | MP0005670_abnormal_white_adipose | 1.73762458 |
| 28 | MP0003866_abnormal_defecation | 1.67833344 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.65592504 |
| 30 | MP0002089_abnormal_postnatal_growth/wei | 1.59120092 |
| 31 | MP0009053_abnormal_anal_canal | 1.57904827 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.57158341 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.56801155 |
| 34 | MP0000490_abnormal_crypts_of | 1.56023972 |
| 35 | MP0002254_reproductive_system_inflammat | 1.53378797 |
| 36 | MP0009379_abnormal_foot_pigmentation | 1.53195116 |
| 37 | MP0001730_embryonic_growth_arrest | 1.52021785 |
| 38 | MP0009697_abnormal_copulation | 1.50160941 |
| 39 | MP0005166_decreased_susceptibility_to | 1.42010022 |
| 40 | MP0003718_maternal_effect | 1.41226263 |
| 41 | MP0000477_abnormal_intestine_morphology | 1.38019743 |
| 42 | MP0004043_abnormal_pH_regulation | 1.37199271 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 1.35323709 |
| 44 | MP0001765_abnormal_ion_homeostasis | 1.29122462 |
| 45 | MP0003119_abnormal_digestive_system | 1.27889252 |
| 46 | MP0003111_abnormal_nucleus_morphology | 1.26718528 |
| 47 | MP0003879_abnormal_hair_cell | 1.23533502 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.23492496 |
| 49 | MP0010030_abnormal_orbit_morphology | 1.21942454 |
| 50 | MP0005381_digestive/alimentary_phenotyp | 1.21602670 |
| 51 | MP0004858_abnormal_nervous_system | 1.18635238 |
| 52 | MP0001663_abnormal_digestive_system | 1.18265693 |
| 53 | MP0005332_abnormal_amino_acid | 1.16145060 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.15731601 |
| 55 | MP0000538_abnormal_urinary_bladder | 1.13643485 |
| 56 | MP0003077_abnormal_cell_cycle | 1.13232223 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.12250388 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.12069793 |
| 59 | MP0000678_abnormal_parathyroid_gland | 1.11161508 |
| 60 | MP0001188_hyperpigmentation | 1.08095977 |
| 61 | MP0003315_abnormal_perineum_morphology | 1.07326359 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03580113 |
| 63 | MP0003195_calcinosis | 1.02514653 |
| 64 | MP0002796_impaired_skin_barrier | 1.02447945 |
| 65 | MP0005365_abnormal_bile_salt | 1.02213996 |
| 66 | MP0003890_abnormal_embryonic-extraembry | 1.01624226 |
| 67 | MP0001849_ear_inflammation | 1.00669765 |
| 68 | MP0005266_abnormal_metabolism | 0.95616890 |
| 69 | MP0005501_abnormal_skin_physiology | 0.95241657 |
| 70 | MP0001756_abnormal_urination | 0.93321676 |
| 71 | MP0005380_embryogenesis_phenotype | 0.91723067 |
| 72 | MP0001672_abnormal_embryogenesis/_devel | 0.91723067 |
| 73 | MP0001873_stomach_inflammation | 0.89907403 |
| 74 | MP0002086_abnormal_extraembryonic_tissu | 0.89167447 |
| 75 | MP0003300_gastrointestinal_ulcer | 0.87021583 |
| 76 | MP0010307_abnormal_tumor_latency | 0.86577220 |
| 77 | MP0002098_abnormal_vibrissa_morphology | 0.86574946 |
| 78 | MP0003984_embryonic_growth_retardation | 0.85597682 |
| 79 | MP0005023_abnormal_wound_healing | 0.84136948 |
| 80 | MP0001664_abnormal_digestion | 0.83798934 |
| 81 | MP0009785_altered_susceptibility_to | 0.83340146 |
| 82 | MP0002088_abnormal_embryonic_growth/wei | 0.83130335 |
| 83 | MP0008469_abnormal_protein_level | 0.80975411 |
| 84 | MP0001845_abnormal_inflammatory_respons | 0.80546783 |
| 85 | * MP0009642_abnormal_blood_homeostasis | 0.79650502 |
| 86 | MP0001697_abnormal_embryo_size | 0.79437166 |
| 87 | MP0008932_abnormal_embryonic_tissue | 0.78165561 |
| 88 | MP0001501_abnormal_sleep_pattern | 0.78072944 |
| 89 | MP0004270_analgesia | 0.76192495 |
| 90 | MP0000604_amyloidosis | 0.73675803 |
| 91 | MP0001764_abnormal_homeostasis | 0.72038446 |
| 92 | * MP0000609_abnormal_liver_physiology | 0.71505373 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.71137265 |
| 94 | MP0003283_abnormal_digestive_organ | 0.70953290 |
| 95 | MP0000230_abnormal_systemic_arterial | 0.70578101 |
| 96 | MP0002111_abnormal_tail_morphology | 0.70375095 |
| 97 | MP0000566_synostosis | 0.70101798 |
| 98 | MP0000516_abnormal_urinary_system | 0.69095115 |
| 99 | MP0005367_renal/urinary_system_phenotyp | 0.69095115 |
| 100 | MP0002085_abnormal_embryonic_tissue | 0.68962925 |
| 101 | MP0002080_prenatal_lethality | 0.68958553 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.68848096 |
| 103 | MP0002166_altered_tumor_susceptibility | 0.68569589 |
| 104 | MP0000350_abnormal_cell_proliferation | 0.67598196 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.67319052 |
| 106 | * MP0005535_abnormal_body_temperature | 0.66845560 |
| 107 | MP0002822_catalepsy | 0.65421501 |
| 108 | MP0010094_abnormal_chromosome_stability | 0.64908265 |
| 109 | MP0000467_abnormal_esophagus_morphology | 0.64808340 |
| 110 | MP0002084_abnormal_developmental_patter | 0.64675918 |
| 111 | * MP0002971_abnormal_brown_adipose | 0.64510918 |
| 112 | MP0008872_abnormal_physiological_respon | 0.64505324 |
| 113 | MP0009764_decreased_sensitivity_to | 0.63022103 |
| 114 | MP0000249_abnormal_blood_vessel | 0.62758564 |
| 115 | MP0003436_decreased_susceptibility_to | 0.62333830 |
| 116 | MP0005058_abnormal_lysosome_morphology | 0.62208122 |
| 117 | MP0003385_abnormal_body_wall | 0.61922944 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.61869739 |
| 119 | MP0003566_abnormal_cell_adhesion | 0.59959407 |
| 120 | MP0009333_abnormal_splenocyte_physiolog | 0.59957983 |
| 121 | MP0005334_abnormal_fat_pad | 0.59623101 |
| 122 | * MP0005448_abnormal_energy_balance | 0.59418463 |
| 123 | MP0000598_abnormal_liver_morphology | 0.59295741 |
| 124 | MP0003724_increased_susceptibility_to | 0.59292258 |
| 125 | MP0005025_abnormal_response_to | 0.59268252 |
| 126 | MP0005451_abnormal_body_composition | 0.58873075 |
| 127 | MP0003941_abnormal_skin_development | 0.58190789 |
| 128 | MP0003329_amyloid_beta_deposits | 0.57096145 |
| 129 | MP0005376_homeostasis/metabolism_phenot | 0.56854594 |
| 130 | MP0009672_abnormal_birth_weight | 0.56523685 |
| 131 | MP0003638_abnormal_response/metabolism_ | 0.55490150 |
| 132 | * MP0002118_abnormal_lipid_homeostasis | 0.52475372 |
| 133 | MP0004197_abnormal_fetal_growth/weight/ | 0.51759283 |
| 134 | MP0003303_peritoneal_inflammation | 0.51452674 |
| 135 | MP0005083_abnormal_biliary_tract | 0.51375702 |
| 136 | MP0005076_abnormal_cell_differentiation | 0.50976236 |
| 137 | * MP0002078_abnormal_glucose_homeostasis | 0.50802036 |
| 138 | MP0000465_gastrointestinal_hemorrhage | 0.49174817 |
| 139 | MP0002896_abnormal_bone_mineralization | 0.48914748 |
| 140 | MP0000858_altered_metastatic_potential | 0.48893399 |
| 141 | MP0003937_abnormal_limbs/digits/tail_de | 0.46917842 |
| 142 | MP0001881_abnormal_mammary_gland | 0.46379841 |
| 143 | * MP0003953_abnormal_hormone_level | 0.44637439 |
| 144 | MP0001835_abnormal_antigen_presentation | 0.42900763 |
| 145 | MP0004947_skin_inflammation | 0.42896796 |
| 146 | MP0001485_abnormal_pinna_reflex | 0.42832617 |
| 147 | * MP0009115_abnormal_fat_cell | 0.42372288 |
| 148 | MP0001790_abnormal_immune_system | 0.42099548 |
| 149 | MP0005387_immune_system_phenotype | 0.42099548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 6.64236522 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.60562135 |
| 3 | Ileus (HP:0002595) | 6.58645865 |
| 4 | Acanthocytosis (HP:0001927) | 5.90588277 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.45280121 |
| 6 | Malnutrition (HP:0004395) | 5.28957968 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 5.27093382 |
| 8 | Abnormality of proline metabolism (HP:0010907) | 4.87419906 |
| 9 | Hydroxyprolinuria (HP:0003080) | 4.87419906 |
| 10 | Complement deficiency (HP:0004431) | 4.58151534 |
| 11 | Abnormality of complement system (HP:0005339) | 4.06329311 |
| 12 | Hyperglycinuria (HP:0003108) | 4.02134337 |
| 13 | Mesangial abnormality (HP:0001966) | 3.99634105 |
| 14 | Cupped ribs (HP:0000887) | 3.85461843 |
| 15 | Poikilocytosis (HP:0004447) | 3.73963553 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.72760483 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 3.60073004 |
| 18 | Glomerulonephritis (HP:0000099) | 3.45333456 |
| 19 | Megaloblastic anemia (HP:0001889) | 3.43768630 |
| 20 | Autoimmune hemolytic anemia (HP:0001890) | 3.39395583 |
| 21 | Pigmentary retinal degeneration (HP:0001146) | 3.36016780 |
| 22 | Deep venous thrombosis (HP:0002625) | 3.31633004 |
| 23 | Widely patent fontanelles and sutures (HP:0004492) | 3.28982354 |
| 24 | Hemorrhage of the eye (HP:0011885) | 3.27520226 |
| 25 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.17448072 |
| 26 | Reticulocytosis (HP:0001923) | 3.15299774 |
| 27 | Hyperactive renin-angiotensin system (HP:0000841) | 3.14046581 |
| 28 | Glycosuria (HP:0003076) | 3.12031886 |
| 29 | Abnormality of urine glucose concentration (HP:0011016) | 3.12031886 |
| 30 | Alkalosis (HP:0001948) | 3.11804201 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.07562150 |
| 32 | Decreased circulating renin level (HP:0003351) | 3.07468026 |
| 33 | Nausea (HP:0002018) | 3.07464871 |
| 34 | Fat malabsorption (HP:0002630) | 3.06192417 |
| 35 | Metabolic alkalosis (HP:0200114) | 3.02210376 |
| 36 | Confusion (HP:0001289) | 3.01579210 |
| 37 | Abnormality of reticulocytes (HP:0004312) | 2.99180704 |
| 38 | Abnormality of vitamin B metabolism (HP:0004340) | 2.92732805 |
| 39 | Steatorrhea (HP:0002570) | 2.91301541 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.86078543 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 2.86078543 |
| 42 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.85362331 |
| 43 | B lymphocytopenia (HP:0010976) | 2.84629293 |
| 44 | Abnormality of B cell number (HP:0010975) | 2.84629293 |
| 45 | Wide cranial sutures (HP:0010537) | 2.84556059 |
| 46 | Intrahepatic cholestasis (HP:0001406) | 2.81839612 |
| 47 | Increased purine levels (HP:0004368) | 2.80115043 |
| 48 | Hyperuricemia (HP:0002149) | 2.80115043 |
| 49 | Hypophosphatemia (HP:0002148) | 2.75915523 |
| 50 | Nephritis (HP:0000123) | 2.72528658 |
| 51 | Gastrointestinal dysmotility (HP:0002579) | 2.72527222 |
| 52 | Reticulocytopenia (HP:0001896) | 2.70524579 |
| 53 | Xanthomatosis (HP:0000991) | 2.65220863 |
| 54 | Nephrolithiasis (HP:0000787) | 2.63953421 |
| 55 | Increased IgE level (HP:0003212) | 2.63235688 |
| 56 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.63113867 |
| 57 | Epidermoid cyst (HP:0200040) | 2.62541242 |
| 58 | Proximal tubulopathy (HP:0000114) | 2.61704030 |
| 59 | Prolonged partial thromboplastin time (HP:0003645) | 2.60301781 |
| 60 | Abdominal distention (HP:0003270) | 2.57924403 |
| 61 | Macrocytic anemia (HP:0001972) | 2.57231925 |
| 62 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.53134020 |
| 63 | Increased mean platelet volume (HP:0011877) | 2.52411145 |
| 64 | Abnormality of renin-angiotensin system (HP:0000847) | 2.51300997 |
| 65 | Congenital sensorineural hearing impairment (HP:0008527) | 2.50731828 |
| 66 | Hyperphosphaturia (HP:0003109) | 2.49122931 |
| 67 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.48523606 |
| 68 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.44543739 |
| 69 | Combined immunodeficiency (HP:0005387) | 2.44025140 |
| 70 | Hypercholesterolemia (HP:0003124) | 2.41392456 |
| 71 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.40861790 |
| 72 | Chronic diarrhea (HP:0002028) | 2.38273813 |
| 73 | Gout (HP:0001997) | 2.37881875 |
| 74 | Facial shape deformation (HP:0011334) | 2.36014027 |
| 75 | Potter facies (HP:0002009) | 2.36014027 |
| 76 | Focal segmental glomerulosclerosis (HP:0000097) | 2.34305442 |
| 77 | Severe combined immunodeficiency (HP:0004430) | 2.33807021 |
| 78 | Abnormality of vitamin metabolism (HP:0100508) | 2.33686632 |
| 79 | Hypotension (HP:0002615) | 2.33141766 |
| 80 | Hyperlipoproteinemia (HP:0010980) | 2.30967356 |
| 81 | Abnormality of nucleobase metabolism (HP:0010932) | 2.28360757 |
| 82 | Hyperparathyroidism (HP:0000843) | 2.25070635 |
| 83 | Multiple enchondromatosis (HP:0005701) | 2.24725115 |
| 84 | Eczematoid dermatitis (HP:0000976) | 2.22468094 |
| 85 | Colon cancer (HP:0003003) | 2.20630201 |
| 86 | Abnormal platelet volume (HP:0011876) | 2.18537605 |
| 87 | Cerebral palsy (HP:0100021) | 2.18322768 |
| 88 | Rectal prolapse (HP:0002035) | 2.16962378 |
| 89 | Abnormality of purine metabolism (HP:0004352) | 2.15974126 |
| 90 | Posterior subcapsular cataract (HP:0007787) | 2.13236795 |
| 91 | Abnormal urine phosphate concentration (HP:0012599) | 2.13012707 |
| 92 | Pancreatitis (HP:0001733) | 2.12687256 |
| 93 | Protuberant abdomen (HP:0001538) | 2.12421041 |
| 94 | Late onset (HP:0003584) | 2.09919842 |
| 95 | Abnormality of glycolysis (HP:0004366) | 2.09258672 |
| 96 | Increased serum pyruvate (HP:0003542) | 2.09258672 |
| 97 | Microretrognathia (HP:0000308) | 2.09102951 |
| 98 | Dicarboxylic aciduria (HP:0003215) | 2.02058109 |
| 99 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02058109 |
| 100 | Enlarged epiphyses (HP:0010580) | 2.00116170 |
| 101 | Renal tubular acidosis (HP:0001947) | 1.99332478 |
| 102 | Irritability (HP:0000737) | 1.96930811 |
| 103 | Joint hemorrhage (HP:0005261) | 1.96847801 |
| 104 | Abnormal biliary tract morphology (HP:0012440) | 1.96688078 |
| 105 | Hyperammonemia (HP:0001987) | 1.94164336 |
| 106 | Abnormal glucose tolerance (HP:0001952) | 1.94091534 |
| 107 | Granulocytopenia (HP:0001913) | 1.93855907 |
| 108 | Dehydration (HP:0001944) | 1.93111619 |
| 109 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.93064535 |
| 110 | Nonimmune hydrops fetalis (HP:0001790) | 1.91479654 |
| 111 | Breast hypoplasia (HP:0003187) | 1.91467785 |
| 112 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90299374 |
| 113 | Metaphyseal cupping (HP:0003021) | 1.90016353 |
| 114 | Woolly hair (HP:0002224) | 1.89840449 |
| 115 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.88906926 |
| 116 | Rickets (HP:0002748) | 1.87956663 |
| 117 | Abnormal tarsal ossification (HP:0008369) | 1.87139740 |
| 118 | Rhabdomyolysis (HP:0003201) | 1.85087837 |
| 119 | Glomerulosclerosis (HP:0000096) | 1.85051083 |
| 120 | Skin nodule (HP:0200036) | 1.84593920 |
| 121 | Short humerus (HP:0005792) | 1.83646705 |
| 122 | Abnormality of abdominal situs (HP:0011620) | 1.80993995 |
| 123 | Abdominal situs inversus (HP:0003363) | 1.80993995 |
| 124 | Subcapsular cataract (HP:0000523) | 1.80919698 |
| 125 | Abnormal gallbladder physiology (HP:0012438) | 1.80779855 |
| 126 | Cholecystitis (HP:0001082) | 1.80779855 |
| 127 | Vascular calcification (HP:0004934) | 1.80707871 |
| 128 | Palpitations (HP:0001962) | 1.79446133 |
| 129 | Abnormality of the costochondral junction (HP:0000919) | 1.79163419 |
| 130 | Eosinophilia (HP:0001880) | 1.79093646 |
| 131 | Metabolic acidosis (HP:0001942) | 1.77977109 |
| 132 | Polycythemia (HP:0001901) | 1.77720359 |
| 133 | Gingivitis (HP:0000230) | 1.77328779 |
| 134 | Delayed CNS myelination (HP:0002188) | 1.76794385 |
| 135 | Thyroiditis (HP:0100646) | 1.76185895 |
| 136 | Pili torti (HP:0003777) | 1.75510613 |
| 137 | Flat acetabular roof (HP:0003180) | 1.75218982 |
| 138 | Abnormal albumin level (HP:0012116) | 1.73380590 |
| 139 | Hypoalbuminemia (HP:0003073) | 1.73380590 |
| 140 | Hypoglycemic coma (HP:0001325) | 1.72872014 |
| 141 | Trismus (HP:0000211) | 1.72193575 |
| 142 | Generalized aminoaciduria (HP:0002909) | 1.71446730 |
| 143 | Abnormality of the 1st metacarpal (HP:0010009) | 1.71082907 |
| 144 | Growth hormone excess (HP:0000845) | 1.70851992 |
| 145 | Biliary tract neoplasm (HP:0100574) | 1.70407474 |
| 146 | Thin bony cortex (HP:0002753) | 1.67346242 |
| 147 | Abnormality of the gastric mucosa (HP:0004295) | 1.64807955 |
| 148 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.62785717 |
| 149 | Villous atrophy (HP:0011473) | 1.62785717 |
| 150 | Delayed epiphyseal ossification (HP:0002663) | 1.61768019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.71535662 |
| 2 | MST4 | 3.69567825 |
| 3 | GRK6 | 3.47540499 |
| 4 | TESK2 | 3.25101723 |
| 5 | BUB1 | 3.17409326 |
| 6 | FGFR4 | 3.01095734 |
| 7 | MAP3K10 | 2.88973910 |
| 8 | MST1R | 2.79688566 |
| 9 | LMTK2 | 2.72719881 |
| 10 | EPHA2 | 2.65284617 |
| 11 | TESK1 | 2.55992033 |
| 12 | NME1 | 2.43347293 |
| 13 | PRKG2 | 2.29106888 |
| 14 | STK10 | 2.26550102 |
| 15 | TTK | 2.10311096 |
| 16 | PAK4 | 2.09685979 |
| 17 | MAP3K8 | 2.08280683 |
| 18 | MAP3K11 | 2.02216895 |
| 19 | MAP2K2 | 2.01870532 |
| 20 | PIK3CA | 2.01492929 |
| 21 | ERN1 | 2.01309480 |
| 22 | PTK6 | 1.87722887 |
| 23 | TYK2 | 1.82228315 |
| 24 | AKT3 | 1.79951782 |
| 25 | WEE1 | 1.78540629 |
| 26 | CDC7 | 1.77784211 |
| 27 | RIPK1 | 1.76907598 |
| 28 | EPHA3 | 1.76349964 |
| 29 | STK39 | 1.71879300 |
| 30 | KDR | 1.63615135 |
| 31 | EIF2AK1 | 1.61039749 |
| 32 | LATS2 | 1.59291146 |
| 33 | FGFR3 | 1.59194756 |
| 34 | NEK1 | 1.48967793 |
| 35 | EPHB1 | 1.42882309 |
| 36 | EPHB2 | 1.41282939 |
| 37 | MAP3K3 | 1.38890263 |
| 38 | PRPF4B | 1.30843114 |
| 39 | NEK2 | 1.29601186 |
| 40 | MAP4K1 | 1.28075467 |
| 41 | MET | 1.27445167 |
| 42 | SCYL2 | 1.25676855 |
| 43 | LRRK2 | 1.25380819 |
| 44 | MAP3K12 | 1.23903897 |
| 45 | MAP2K3 | 1.23354423 |
| 46 | OXSR1 | 1.22102764 |
| 47 | MAP3K1 | 1.21910338 |
| 48 | MAP3K2 | 1.17151842 |
| 49 | TAOK1 | 1.16690002 |
| 50 | EPHA4 | 1.15149989 |
| 51 | RIPK4 | 1.14717800 |
| 52 | CDK7 | 1.10972061 |
| 53 | PTK2 | 1.10379135 |
| 54 | PDPK1 | 1.05457483 |
| 55 | AURKB | 1.05067661 |
| 56 | LIMK1 | 1.03760707 |
| 57 | STK24 | 1.03526234 |
| 58 | MAP2K6 | 1.03515143 |
| 59 | TNIK | 0.96536460 |
| 60 | CDC42BPA | 0.95731400 |
| 61 | PRKCI | 0.93950292 |
| 62 | CDK12 | 0.89827881 |
| 63 | BMX | 0.89819024 |
| 64 | TGFBR1 | 0.87544040 |
| 65 | DYRK1B | 0.87255474 |
| 66 | NLK | 0.86899198 |
| 67 | NUAK1 | 0.85537111 |
| 68 | PASK | 0.84633409 |
| 69 | PAK1 | 0.84248575 |
| 70 | PRKACG | 0.83134949 |
| 71 | BRSK2 | 0.81511945 |
| 72 | TAOK2 | 0.80333472 |
| 73 | CDK6 | 0.75717219 |
| 74 | PDK1 | 0.74925948 |
| 75 | PLK1 | 0.74528876 |
| 76 | KSR2 | 0.74347356 |
| 77 | ACVR1B | 0.73142965 |
| 78 | LATS1 | 0.71199979 |
| 79 | CDK4 | 0.71065556 |
| 80 | TSSK6 | 0.69422981 |
| 81 | RET | 0.66258879 |
| 82 | EIF2AK3 | 0.65030719 |
| 83 | PBK | 0.63860073 |
| 84 | TBK1 | 0.60529232 |
| 85 | JAK1 | 0.60317168 |
| 86 | PRKCZ | 0.58792199 |
| 87 | AKT2 | 0.58231197 |
| 88 | CHEK2 | 0.57493376 |
| 89 | PLK4 | 0.56835395 |
| 90 | RPS6KB2 | 0.54293416 |
| 91 | ICK | 0.53839221 |
| 92 | IRAK1 | 0.53586359 |
| 93 | FGFR1 | 0.52919692 |
| 94 | PRKCA | 0.52383189 |
| 95 | SMG1 | 0.52275948 |
| 96 | SRC | 0.50980534 |
| 97 | AURKA | 0.49398144 |
| 98 | MAPK11 | 0.49226836 |
| 99 | BCKDK | 0.49078318 |
| 100 | CSF1R | 0.48031500 |
| 101 | ALK | 0.47325617 |
| 102 | BRAF | 0.47190708 |
| 103 | TLK1 | 0.47145940 |
| 104 | JAK2 | 0.46865004 |
| 105 | PKN2 | 0.46536275 |
| 106 | EEF2K | 0.45081225 |
| 107 | MAP2K1 | 0.44652029 |
| 108 | STK4 | 0.44185513 |
| 109 | ABL2 | 0.44131092 |
| 110 | CAMK2D | 0.43172901 |
| 111 | ZAP70 | 0.41660366 |
| 112 | ERBB2 | 0.40675243 |
| 113 | DDR2 | 0.40501366 |
| 114 | FYN | 0.39997368 |
| 115 | CHEK1 | 0.39251603 |
| 116 | MATK | 0.39197660 |
| 117 | YES1 | 0.38864375 |
| 118 | PIM2 | 0.38182825 |
| 119 | SRPK1 | 0.37978044 |
| 120 | MELK | 0.37238300 |
| 121 | STK3 | 0.36978734 |
| 122 | MYLK | 0.36730638 |
| 123 | STK38L | 0.36626969 |
| 124 | SIK1 | 0.35180452 |
| 125 | IKBKE | 0.35142257 |
| 126 | BRSK1 | 0.34532779 |
| 127 | CSK | 0.34487573 |
| 128 | ATR | 0.32540133 |
| 129 | PIM1 | 0.32387237 |
| 130 | IGF1R | 0.32060349 |
| 131 | ITK | 0.31050471 |
| 132 | WNK4 | 0.30489468 |
| 133 | PRKAA2 | 0.30427997 |
| 134 | PAK2 | 0.30299093 |
| 135 | PRKCD | 0.30251751 |
| 136 | PLK3 | 0.29863631 |
| 137 | BMPR2 | 0.28051713 |
| 138 | TRIB3 | 0.28041032 |
| 139 | FER | 0.27806246 |
| 140 | PDGFRA | 0.26741235 |
| 141 | CAMK2G | 0.26734466 |
| 142 | PDK2 | 0.26107134 |
| 143 | MAP3K14 | 0.25946802 |
| 144 | IRAK3 | 0.25878202 |
| 145 | MAPKAPK2 | 0.25355767 |
| 146 | VRK1 | 0.25254294 |
| 147 | TGFBR2 | 0.24674396 |
| 148 | RPS6KA4 | 0.24233735 |
| 149 | PDK3 | 0.24205723 |
| 150 | SYK | 0.21840357 |
| 151 | RPS6KA2 | 0.20137589 |
| 152 | JAK3 | 0.19987591 |
| 153 | CASK | 0.19254907 |
| 154 | LYN | 0.18638182 |
| 155 | MAPK7 | 0.18525592 |
| 156 | NEK6 | 0.17892930 |
| 157 | PRKACA | 0.17764280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 5.44923524 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.98471866 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.35909949 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.28584348 |
| 5 | Mineral absorption_Homo sapiens_hsa04978 | 3.54014373 |
| 6 | Galactose metabolism_Homo sapiens_hsa00052 | 3.06291078 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.45398626 |
| 8 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.41569772 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.34664941 |
| 10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.22916621 |
| 11 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.19731439 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.08881844 |
| 13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.00146247 |
| 14 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.99280283 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.87310233 |
| 16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84351919 |
| 17 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.74858116 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62340735 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.60684367 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.52974818 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.49979768 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.49434812 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.48147307 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.38812325 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.38661930 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.38321781 |
| 27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.36395448 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.35940110 |
| 29 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.32069722 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27401954 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21158611 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20892165 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.20192212 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.17368242 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15195246 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09128325 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.09121032 |
| 38 | Ribosome_Homo sapiens_hsa03010 | 1.03865406 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.01489099 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99439557 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98535853 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95684205 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.94327431 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.90964610 |
| 45 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89432681 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87245872 |
| 47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86800025 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82745429 |
| 49 | Mismatch repair_Homo sapiens_hsa03430 | 0.80059860 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76116638 |
| 51 | Asthma_Homo sapiens_hsa05310 | 0.74963370 |
| 52 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73973577 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71376308 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70717658 |
| 55 | Spliceosome_Homo sapiens_hsa03040 | 0.70558469 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68853480 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68222140 |
| 58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.63815908 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63804603 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.63292176 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62869982 |
| 62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62836645 |
| 63 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59301665 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58770576 |
| 65 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57393234 |
| 66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57122571 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55753037 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55324354 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54559685 |
| 70 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54139267 |
| 71 | RNA transport_Homo sapiens_hsa03013 | 0.54137490 |
| 72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53840922 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.53758336 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53210240 |
| 75 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.53086162 |
| 76 | Proteasome_Homo sapiens_hsa03050 | 0.53012260 |
| 77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52403340 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52204538 |
| 79 | Cell cycle_Homo sapiens_hsa04110 | 0.52032370 |
| 80 | Allograft rejection_Homo sapiens_hsa05330 | 0.50608311 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50541026 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50505321 |
| 83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48254173 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47561247 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46667536 |
| 86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.46013200 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.45726196 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.44439190 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.42427631 |
| 90 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.42226954 |
| 91 | Adherens junction_Homo sapiens_hsa04520 | 0.41790102 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.40808864 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.40756539 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38715255 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38365606 |
| 96 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36532938 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36048057 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35729873 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34278031 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32016811 |
| 101 | Pertussis_Homo sapiens_hsa05133 | 0.30107243 |
| 102 | Peroxisome_Homo sapiens_hsa04146 | 0.29404361 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28822999 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.28078098 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.27782594 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.27138573 |
| 107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.27070953 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.25494093 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.24648167 |
| 110 | RNA polymerase_Homo sapiens_hsa03020 | 0.24275778 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23963229 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23250153 |
| 113 | Renin secretion_Homo sapiens_hsa04924 | 0.21727895 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21629957 |
| 115 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.21089102 |
| 116 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.20993024 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.20247354 |
| 118 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.17070550 |
| 119 | Homologous recombination_Homo sapiens_hsa03440 | 0.15206136 |
| 120 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.14991592 |
| 121 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.14930692 |
| 122 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.14688903 |
| 123 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.13501132 |
| 124 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.13121682 |
| 125 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.12874516 |
| 126 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.11778627 |
| 127 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.11770736 |
| 128 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.11285350 |
| 129 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.10327911 |
| 130 | Leishmaniasis_Homo sapiens_hsa05140 | 0.10043930 |
| 131 | Salmonella infection_Homo sapiens_hsa05132 | 0.08259938 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.06884822 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.06829647 |
| 134 | Hepatitis C_Homo sapiens_hsa05160 | 0.05615484 |
| 135 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05550590 |
| 136 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.05400547 |
| 137 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.04890206 |

